ClearOne VE402061 Compliance Statement

COMMUNICATION CERTIFICATION LABORATORY TEST REPORT: 73-6687

FCC ID: FBIVE402061

Page 44 of 57

Exhibit 8: User’s Manual

The user’s manual was sent as a separate pdf file. The
compliance statement shown below is enclosed on pages 12-13 of
the manual.

FCC
The Gentner Venture-Express Assistive Listening Transmitter
complies with Part 95 of the FCC
Rules.

This devise may not interfere with TV reception or federal
government radar, and must accept any interference received,
including interference that may cause undesired operation.

This transmitter is authorized by rule under the Low Power Radio
Service (47 C.F.R. Part 95) and must not cause harmful
interference to TV reception or United States Navy SPASUR
installations. You do not need an FCC license to operate this
transmitter. This transmitter may only be used to provide:
auditory assistance to persons with disabilities, persons who
require language translation, or persons in educational settings;
health care services to the ill; law enforcement tracking
services under agreement with a law enforcement agency; or
automated maritime telecommunications system (AMTS) network
control
communications. Two-way voice communications and all other types
of uses not mentioned above are expressly prohibited.

Industry Canada
This device complies with the requirements of the Department of
Communications (DOC of Canada), as specified in document RSS-210.
Operation is subject to the following two conditions: 1) This
device may not cause harmful interference; 2) this device must
accept any interference received, including interference that may
cause any undesired operation.

If TV channel 13 is used in the area, the installer of this
system shall reduce or adjust the RF radiated power so that near­by TV channel 13 receivers do not receive radio interference from
the system. (A test with a TV receiver equipped with “rabbit-ear
antenna” and tuned to TV channel 13 should be conducted, at the
perimeter of the user’s intended coverage area.)

Exhibit 8